The RegeneRx Biopharmaceuticals (RGRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 11,400.00%, with a year-to-date return of 11,400.00%. In the past month, the stock has increased 80,400.00%, reflecting recent market activity.
As of the latest close, RegeneRx Biopharmaceuticals traded at $0.16 with a market cap of $0.00 and volume of 5,251 shares. Five years ago, the stock traded at a split-adjusted price of $45.00, representing a 99.64% decrease over that period. At the time, it had a market cap of $60.05 million and a volume of 177 shares.
